Stockreport

Olema Oncology to Participate in Upcoming Investor Conferences in June

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focus [Read more]